Cantor Fitzgerald Starts VolitionRX (VNRX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
VolitionRx Limited to Present at Conferences in March 2021
March 8, 2021 4:15 PM ESTAUSTIN, Texas, March 8, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, Cameron Reynolds, and its Executive Vice President, Investor Relations, Scott Powell, are scheduled to present at six conferences in March 2021.
During the conferences, Mr. Reynolds and Dr. Powell will outline Volition's business, clinical, regulatory and operational milestones.
Details of the conference presentations (all virtual) are as follows:
H.C. Wainwright Global Life Sciences Conference - March 9-10, 2021Presentation: Tuesday March 9 at 7:00 am ETRegister:... More



